Arrowhead Pharmaceuticals, Inc.
ARWR
$55.05
$0.040.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 66.06% | 35.43% | 106.73% | 110.27% | 158.15% |
| Total Receivables | 8,654.84% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 71.40% | 14.64% | 157.33% | 115.65% | -10.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 215.95% | 81.94% | 140.60% | 41.83% | -44.05% |
| Total Current Assets | 105.84% | 36.69% | 110.40% | 109.59% | 139.82% |
|
|
|||||
| Total Current Assets | 105.84% | 36.69% | 110.40% | 109.59% | 139.82% |
| Net Property, Plant & Equipment | -2.31% | -1.13% | 1.14% | 6.28% | 14.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -20.90% | -19.87% | -18.93% | -18.07% | -17.28% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -54.23% | -69.01% | -69.66% | 524.76% | 1,228.88% |
| Total Assets | 58.25% | 21.54% | 56.22% | 64.74% | 61.86% |
|
|
|||||
| Total Accounts Payable | 127.83% | 55.20% | 24.48% | 17.12% | 224.15% |
| Total Accrued Expenses | 36.24% | 19.11% | 47.52% | 117.56% | 54.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 480.68% | 645.65% | 676.64% | 1,258.22% | 139.26% |
| Total Finance Division Other Current Liabilities | 5,333.91% | 417.16% | 222.14% | 462.31% | -74.35% |
| Total Other Current Liabilities | 5,333.91% | 417.16% | 222.14% | 462.31% | -74.35% |
| Total Current Liabilities | 270.56% | 89.48% | 101.14% | 238.38% | 47.13% |
|
|
|||||
| Total Current Liabilities | 270.56% | 89.48% | 101.14% | 238.38% | 47.13% |
| Long-Term Debt | -28.69% | -20.73% | 66.83% | 99.76% | 175.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.56% | -6.23% | -5.67% | -5.37% | -5.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.76% | -7.05% | 58.01% | 93.43% | 111.59% |
|
|
|||||
| Common Stock & APIC | 19.72% | 18.48% | 18.69% | 19.11% | 39.87% |
| Retained Earnings | 11.25% | -0.10% | -10.20% | -11.21% | -55.20% |
| Treasury Stock & Other | -1,223.86% | -1,084.21% | 642.76% | 500.91% | 429.64% |
| Total Common Equity | 980.88% | 151.32% | 58.01% | 41.24% | -67.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 980.88% | 151.32% | 58.01% | 41.24% | -67.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -264.23% | 564.96% | -129.75% | -92.21% | -73.80% |
| Total Equity | 903.47% | 163.48% | 53.35% | 38.11% | -67.72% |
|
|
|||||